Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of concentrate main carbohydrate type on methane emissions, milk production and feeding behavior in grazing late-lactation dairy cows.

Frontiers in veterinary science·2026
Same author

Effects of Colostrum Source, Dose and Processing on <i>In Vitro</i> Rumen Fermentation in Weaned Lambs.

Animals : an open access journal from MDPI·2026
Same author

Ruminal pH Dynamics and Milk Production Response to Concentrate Supplementation in Pasture-Based Dairy Cows.

Animals : an open access journal from MDPI·2026
Same author

Influence of sire fertility on the metabolism of in vitro produced embryos.

Reproduction & fertility·2026
Same author

Associations between subclinical bovine respiratory disease, growth patterns, and the nasal and fecal microbiota in dairy replacement heifers: a retrospective study.

Frontiers in veterinary science·2026
Same author

<i>De novo</i> COVID-19-associated insulin resistance drives dysregulated neutrophil extracellular trap formation (NETosis) four months after infection.

Frontiers in immunology·2026

Related Experiment Video

Updated: Jun 21, 2026

The Use of an Automated System GreenFeed to Monitor Enteric Methane and Carbon Dioxide Emissions from Ruminant Animals
11:02

The Use of an Automated System GreenFeed to Monitor Enteric Methane and Carbon Dioxide Emissions from Ruminant Animals

Published on: September 7, 2015

21.7K

Feed additives for methane mitigation: Recommendations for testing enteric methane-mitigating feed additives in

Alexander N Hristov1, André Bannink2, Marco Battelli3

  • 1Department of Animal Science, The Pennsylvania State University, University Park, PA 16802.

Journal of Dairy Science
|December 26, 2024
PubMed
Summary
This summary is machine-generated.

Rigorous testing standards are needed for antimethanogenic feed additives (AMFA) to reduce enteric methane emissions in ruminants. This review outlines guidelines for study design, data analysis, and methane measurement to ensure reliable efficacy confirmation.

Keywords:
enteric methane mitigationfeed additiveguidelineruminant animal

More Related Videos

Lab-Scale Model to Evaluate Odor and Gas Concentrations Emitted by Deep Bedded Pack Manure
06:52

Lab-Scale Model to Evaluate Odor and Gas Concentrations Emitted by Deep Bedded Pack Manure

Published on: July 19, 2018

6.3K
Author Spotlight: Advancing Anaerobic Microbiota Research Using a Novel Respirometry Protocol
06:11

Author Spotlight: Advancing Anaerobic Microbiota Research Using a Novel Respirometry Protocol

Published on: April 26, 2024

1.1K

Related Experiment Videos

Last Updated: Jun 21, 2026

The Use of an Automated System GreenFeed to Monitor Enteric Methane and Carbon Dioxide Emissions from Ruminant Animals
11:02

The Use of an Automated System GreenFeed to Monitor Enteric Methane and Carbon Dioxide Emissions from Ruminant Animals

Published on: September 7, 2015

21.7K
Lab-Scale Model to Evaluate Odor and Gas Concentrations Emitted by Deep Bedded Pack Manure
06:52

Lab-Scale Model to Evaluate Odor and Gas Concentrations Emitted by Deep Bedded Pack Manure

Published on: July 19, 2018

6.3K
Author Spotlight: Advancing Anaerobic Microbiota Research Using a Novel Respirometry Protocol
06:11

Author Spotlight: Advancing Anaerobic Microbiota Research Using a Novel Respirometry Protocol

Published on: April 26, 2024

1.1K

Area of Science:

  • Ruminant nutrition and environmental science.
  • Agricultural technology and sustainability.

Background:

  • Enteric methane emissions from ruminants contribute significantly to greenhouse gases.
  • Antimethanogenic feed additives (AMFA) are a promising mitigation strategy.
  • Current testing standards for AMFA lack scientific rigor and standardization.

Purpose of the Study:

  • To provide guidelines for scientifically-based testing of AMFA in ruminants.
  • To establish standards for evaluating antimethanogenic and production effects of feed additives.
  • To ensure reliable efficacy confirmation before making mitigation claims.

Main Methods:

  • Recommendations for study design, including hypothesis formulation and statistical analysis.
  • Guidelines for assessing dietary effects, associative effects with other strategies, and production responses.
  • Evaluation of appropriate methane measurement techniques (respiration chambers, SF6, GreenFeed) and physiological/health impacts.

Main Results:

  • Proposed comprehensive framework for evaluating AMFA efficacy and safety.
  • Highlighted need for long-term studies and experiments representative of production systems.
  • Emphasized importance of collecting and analyzing production, health, and product quality data.

Conclusions:

  • Standardized, scientifically-sound testing is crucial for validating AMFA.
  • Adherence to proposed guidelines will ensure practical and applicable results.
  • Efficacy claims for AMFA should only be made post-confirmation through rigorous animal studies.